Rheumatology

Rheumatology Expert Witness

Rheumatology expert witnesses provide critical testimony in cases involving delayed diagnosis of autoimmune diseases, inappropriate immunosuppressive therapy, and the distinction between inflammatory and degenerative conditions. These specialists evaluate whether rheumatologic care met accepted standards and whether diagnostic delays caused irreversible joint destruction, organ damage, or disability. Rheumatology experts are frequently retained in disability determinations, workers' compensation disputes, and malpractice claims where autoimmune conditions were missed or mismanaged.

Autoimmune and inflammatory diseases present diagnostic challenges that frequently lead to litigation. Rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis can take years to diagnose, and delays in initiating disease-modifying therapy often result in irreversible damage. A rheumatology expert can evaluate whether serologic testing was appropriately ordered and interpreted, whether treatment escalation followed current ACR guidelines, and whether a physician should have recognized the clinical presentation of an autoimmune condition earlier. In disability and insurance disputes, rheumatology experts assess functional capacity and distinguish inflammatory disease activity from subjective symptom reports. Product liability cases involving biologic medications such as TNF inhibitors require an expert who understands both the therapeutic benefits and the infectious and malignancy risks of immunosuppression. For damages testimony, the rheumatology expert projects the trajectory of progressive joint destruction in inadequately treated rheumatoid arthritis — including the number and timing of anticipated joint replacements, the lifetime costs of biologic therapies averaging $30,000 to $80,000 annually, and the permanent disability resulting from delayed initiation of disease-modifying therapy. The expert quantifies irreversible organ damage from lupus including end-stage renal disease requiring dialysis, and the cumulative cost of immunosuppressive management over the patient's remaining life expectancy.

Rheumatology experts address clinical issues including interpretation of ANA panels, anti-CCP antibodies, HLA-B27 testing, and inflammatory markers. They evaluate adherence to treat-to-target strategies for rheumatoid arthritis, monitoring protocols for methotrexate and biologic therapies, and screening for tuberculosis before initiating TNF inhibitors. Common areas of testimony include delayed diagnosis of lupus nephritis, failure to recognize giant cell arteritis before vision loss, inadequate monitoring for hydroxychloroquine retinal toxicity, and misdiagnosis of fibromyalgia when an inflammatory condition was present. Anchor connects attorneys with board-certified rheumatologists who maintain active clinical practices treating the full spectrum of autoimmune and musculoskeletal diseases. In damages cases, the rheumatology expert establishes the permanence of joint destruction and organ damage resulting from delayed autoimmune diagnosis, projecting the lifetime costs of biologic and targeted synthetic DMARD therapy, serial joint replacement surgeries, and the monitoring required for immunosuppressive side effects including infection surveillance and malignancy screening. The expert quantifies permanent functional disability using validated disease activity scores and projects future dialysis or transplant costs for patients with lupus nephritis that progressed due to treatment delay.